{"podcast":{"title":"UK News Today | 2 Min News | The Daily News Now!","slug":"uk-news-today-2-min-news-the-daily-news-now-7493829","podcast_index_feed_id":7493829,"rss_url":"https://feeds.fastcast.ai/uk-today-2-min-news.xml","website_url":"https://thednn.ai/","image_url":"https://image.fastcast.ai/podcasts/uk-today-2-min-news_1.jpg","author":"The Daily News Now!","episode_count":5895,"summary":"Hosted by Corey with the Story, UK News Today delivers daily coverage of the biggest stories shaping the United Kingdom with fast, focused updates on national news, politics, business, economy, public safety, and cultural developments. From breaking headlines to ongoing national conversations, the show keeps you informed on what matters most across the UK. Each short episode highlights what matters most—including key updates, national trends, and major storylines—produced by AI for speed, consistency, and clarity. Part of The Daily News Now network, UK News Today is built for listeners who want reliable national news coverage in a quick, easy-to-digest format. Advertise on DNN: advertise@thednn.ai","last_synced_at":"2026-07-27T08:19:40.005460+00:00","page_url":"https://stenobird.com/podcast/uk-news-today-2-min-news-the-daily-news-now-7493829"},"episode":{"title":"Cancer Jab Vanishes Tumors in Hard-to-Treat Cases","slug":"cancer-jab-vanishes-tumors-in-hard-to-treat-cases","published_at":"2026-05-30T17:11:10+00:00","page_url":"https://stenobird.com/podcast/uk-news-today-2-min-news-the-daily-news-now-7493829/cancer-jab-vanishes-tumors-in-hard-to-treat-cases","show_page_url":"https://stenobird.com/podcast/uk-news-today-2-min-news-the-daily-news-now-7493829","url":"https://api.fastcast.ai/audio/93c69540-54d4-4d21-a722-4629a5422b5d.mp3","audio_url":"https://api.fastcast.ai/audio/93c69540-54d4-4d21-a722-4629a5422b5d.mp3","summary":"Scientists just dropped a game-changer: a new cancer jab called amivantamab wiped out tumors in 15 patients with advanced, treatment-resistant head and neck cancer — some even completely vanished. This triple-action drug works by blocking growth, stopping escape routes, and revving up the immune system. In a trial of over 100 patients, more than a third saw tumors shrink, and survivors lived over 12 months on average. Patients report dramatic improvements — one regained the ability to eat and speak normally. Administered under the skin, it’s far easier than IV treatments, with mostly mild side effects. Experts call the results unprecedented — especially for HPV-negative cancers, which are notoriously hard to treat. This breakthrough shines a light on the power of relentless cancer research and offers hope to those with few options left. Support the show: Get a discount at https://solipillow.com/discount/dnn. Advertise on DNN: advertise@thednn.ai This is an automated, high-level news summary based on public reporting. Report issues to feedback@thednn.ai. View sources & latest updates: https://sources.thednn.ai/29483218cf8a4bac","meta_description":"Scientists just dropped a game-changer: a new cancer jab called amivantamab wiped out tumors in 15 patients with advanced, treatment-resistant head and ne…","key_points":[],"chapters":[],"topics":[],"duration_seconds":112,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/uk-news-today-2-min-news-the-daily-news-now-7493829/episodes/cancer-jab-vanishes-tumors-in-hard-to-treat-cases/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/uk-news-today-2-min-news-the-daily-news-now-7493829/cancer-jab-vanishes-tumors-in-hard-to-treat-cases.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}}